Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEZURSO 2
2023-504086-23-00Phase 3Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bezafibrate in primary biliary cholangitis (PBC) (3 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Complete biochemical response at week 48. Planned start Sep 2024; status: authorised.
02
Drugs
bezafibrate
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on 2023-504086-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504086-23-00.